German biotech company MorphoSys buys US rival for $1.7B
Germany-based MorphoSys AG said Wednesday that it is buying U.S. rival Constellation Pharmaceuticals Inc. in a deal valuing the biotech company at $1.7 billion.
- Next story France widens COVID vaccine drive to 12 to 18-year-olds
- Previous story Vaccine protection may diminish need for yearly boosters
Explore more
- Next-generation sutures can deliver drugs, prevent infections and monitor wounds
Sutures are used to close wounds and speed up the natural healing... - Chauvin Verdict Brings a Rare Rebuke of Police Misconduct
Public gatherings were largely celebratory after Derek Chauvin was convicted of murdering... - A Family Sought Revenge Against a Tormentor. They Shot the Wrong Man, Police Say.
Members of a family in Texas who were being harassed have been... - People at high genetic risk for colorectal cancer benefit more from lifestyle changes
People with a high polygenic risk score for colorectal cancer could benefit... - Histamine-suppressing drugs found to reduce benefits of exercise
A team of researchers from Ghent University and the University of Copenhagen... - Virus-hit Papua New Guinea starts vaccine roll-out
Papua New Guinea’s prime minister launched a nationwide coronavirus vaccine roll-out Tuesday,... - The Origin of the Rooftop Concert: Before the Beatles Came Jefferson Airplane, and Before Them, Brazilian Singer Roberto Carlos (1967)
When did the first rooftop concert happen? Probably not long after construction... - 2021 French Open: What to Watch on Sunday
Daniil Medvedev, Stefanos Tsitsipas and Serena Williams lead the charge as the... - This Fitbit Sense price drop for Prime Day has to be seen to be believed
This is a smart-looking watch, with its sleek design and illuminated face... - Police identify toddler who died crossing the English Channel
The body of a toddler that washed up on Karmøy Island earlier...